Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Sep;16(3):200069.
doi: 10.1183/20734735.0069-2020.

Outpatient treatment of pulmonary embolism

Elena Bellou  1   2 , Elli Keramida  1   2 , Ioannis Karampinis  3 , Evaggelos Dimakakos  4 , Panagiotis Misthos  3 , Panagiotis Demertzis  1 , Georgia Hardavella  1
Affiliations
Review

Outpatient treatment of pulmonary embolism

Elena Bellou et al. Breathe (Sheff). 2020 Sep.

Abstract

Over the past decade there has been an increasing trend to manage many conditions traditionally treated during a hospital admission as outpatients. Evidence is increasing to support this approach in patients with pulmonary embolism (PE). In this article, we review the current status of outpatient management of confirmed PE and present a pragmatic approach for clinical healthcare settings.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: E. Bellou has nothing to disclose. Conflict of interest: E. Keramida has nothing to disclose. Conflict of interest: I. Karampinis has nothing to disclose. Conflict of interest: E. Dimakakos has nothing to disclose. Conflict of interest: P. Misthos has nothing to disclose. Conflict of interest: P. Demertzis has nothing to disclose. Conflict of interest: G. Hardavella has nothing to disclose.

Figures

Figure 1
Figure 1
A flowchart for the selection criteria, risk assessment, etc. regarding suitability for outpatient management in confirmed PE.
See this image and copyright information in PMC

References

    1. Raskob GE, Angchaisuksiri P, Blanco AN, et al. . Thrombosis: a major contributor to global disease burden. Arterioscler Thromb Vasc Biol 2014; 34: 2363–2371. doi:10.1161/ATVBAHA.114.304488 - DOI - PubMed
    1. Wendelboe AM, Raskob GE.. Global burden of thrombosis: epidemiologic aspects. Circ Res 2016; 118: 1340–1347. doi:10.1161/CIRCRESAHA.115.306841 - DOI - PubMed
    1. Keller K, Hobohm L, Ebner M, et al. . Trends in thrombolytic treatment and outcomes of acute pulmonary embolism in Germany. Eur Heart J 2020; 41: 522–529. doi:10.1093/eurheartj/ehz236 - DOI - PubMed
    1. Barco S, Woersching AL, Spyropoulos AC, et al. . European Union-28: an annualised cost-of-illness model for venous thromboembolism. Thromb Haemost 2016; 115: 800–808. doi:10.1160/TH15-08-0670 - DOI - PubMed
    1. Cohen AT, Agnelli G, Anderson FA, et al. . Venous thromboembolism (VTE) in Europe. The number of VTE events and associated morbidity and mortality. Thromb Haemost 2007; 98: 756–764. doi:10.1160/TH07-03-0212 - DOI - PubMed

LinkOut - more resources